APA (7th ed.) Citation

Blackwell, K. L., Pegram, M. D., Tan-Chiu, E., Schwartzberg, L. S., Arbushites, M. C., Maltzman, J. D., . . . Burstein, H. J. (2009). Single-agent lapatinib for HER2-overexpressing advanced or metastatic breast cancer that progressed on first- or second-line trastuzumab-containing regimens. Annals of Oncology, 20(6), 1026. https://doi.org/10.1093/annonc/mdn759

Chicago Style (17th ed.) Citation

Blackwell, K. L., et al. "Single-agent Lapatinib for HER2-overexpressing Advanced or Metastatic Breast Cancer That Progressed on First- or Second-line Trastuzumab-containing Regimens." Annals of Oncology 20, no. 6 (2009): 1026. https://doi.org/10.1093/annonc/mdn759.

MLA (9th ed.) Citation

Blackwell, K. L., et al. "Single-agent Lapatinib for HER2-overexpressing Advanced or Metastatic Breast Cancer That Progressed on First- or Second-line Trastuzumab-containing Regimens." Annals of Oncology, vol. 20, no. 6, 2009, p. 1026, https://doi.org/10.1093/annonc/mdn759.